Evidence map›Paper›PMID 38234220›Full record

Observational studyUnited European gastroenterology journal2024

Incidence, characteristics, and predictive factors of post-colonoscopy colorectal cancer.

Sandra Baile-Maxía, Carolina Mangas-Sanjuan, Noelia Sala-Miquel, Claudia Barquero, Germán Belda, Gloria García-Del-Castillo, Antonio García-Herola, Juan Carlos Penalva, María-Dolores Picó, María-José Poveda and 3 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in United European gastroenterology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Combating Post-colonoscopy Colorectal Cancer: Insight from the Trials and Cohort Studies.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Colorectal cancer screening.Singapore medical journal · 2025
    Article
  10. Review
  11. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sandra Baile-MaxíaGastroenterology Department, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain.ORCID 0000-0002-5387-6220
Carolina Mangas-SanjuanGastroenterology Department, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain.
Noelia Sala-MiquelGastroenterology Department, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain.
Claudia BarqueroGastroenterology Department, Hospital Universitario de Torrevieja, Torrevieja, Spain.
Germán BeldaGastroenterology Department, Hospital Universitario Vega Baja, Orihuela, Spain.
Gloria García-Del-CastilloGastroenterology Department, Hospital Universitario de San Juan, San Juan de Alicante, Spain.
Antonio García-HerolaGastroenterology Department, Hospital Universitario Marina Baixa, Villajoyosa, Spain.
Juan Carlos PenalvaGastroenterology Department, Hospital Universitario del Vinalopó, Elche, Spain.
María-Dolores PicóGastroenterology Department, Hospital General Universitario de Elche, Elche, Spain.
María-José PovedaGastroenterology Department, Hospital Virgen de Los Lírios, Alcoy, Spain.
Félix de-VeraGastroenterology Department, Hospital General Universitario de Elda, Elda, Spain.
Pedro ZapaterClinical Pharmacology Unit, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Universidad Miguel Hernández, IDIBE, CIBERehd, Alicante, Spain.
Rodrigo JoverGastroenterology Department, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain.

Funding

Asociación para la Investigación en Gastroenterología de la Provincia de AlicanteFundación de Investigación Biomédica de la Comunidad Valenciana-Instituto de Investigación Sanitaria y Biomédica de Alicante Foundation UGP-190276Instituto de Salud Carlos III PI17/01756Instituto de Salud Carlos III PI20/01527Sociedad Valenciana de Patología Digestiva
6 · The paper itself

Abstract

backgroundPost-colonoscopy colorectal cancer (PCCRC) is colorectal cancer (CRC) diagnosed after a colonoscopy in which no cancer is found.

objectiveAs PCCRC has become an important quality indicator, we determined its rates, characteristics, and index colonoscopy-related predictive factors.

methodsWe carried out a multicenter, observational, retrospective study between 2015 and 2018. Rates were calculated for PCCRC developing up to 10 years after colonoscopy. PCCRC was categorized according to the most plausible explanation using World Endoscopy Organization methodology. Our PCCRC population was compared to a control cohort without CRC matched 1:4 by sex, age, index colonoscopy date, indication, endoscopist, and hospital.

resultsOne hundred seven PCCRC and 2508 detected CRC were diagnosed among 101,524 colonoscopy (0.1%), leading to rates of 0.4%, 2.2%, 3.1%, and 4.1% at 1, 3, 5, and 10 years, respectively. PCCRC was in right (42.4%), left (41.4%), and transverse (16.4%) colon with 31.5% at stage I, 24.7% stage II, 32.6% stage III, and 11.2% stage IV. Twenty point three percent were classified as incomplete resection, 5.4% as unresected lesions, 48.6% as missed lesions with adequate colonoscopy, and 25.7% as missed lesions with inadequate colonoscopy. The median time from colonoscopy to PCCRC was 42 months. Previous inadequate preparation (OR 3.05, 95%CI 1.73-5.36) and piecemeal polypectomy (OR 19.89, 95%CI 8.67-45.61) were independently associated with PCCRC.

conclusionsIn our population, 4.1% of CRC cases were PCCRC. Most of these lesions were in right colon and attributable to lesions not visualized despite adequate bowel cleansing. Previous inadequate cleansing and piecemeal polypectomy were associated with PCCRC.

Indexed as

Colorectal NeoplasmsColonoscopyHumansIncidenceRetrospective StudiesRisk Factorscolonoscopycolorectal cancercolorectal neoplasmsincidence

Identifiers

PMID38234220
PMCPMC11017761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.